JP2022553060A5 - - Google Patents

Info

Publication number
JP2022553060A5
JP2022553060A5 JP2022523653A JP2022523653A JP2022553060A5 JP 2022553060 A5 JP2022553060 A5 JP 2022553060A5 JP 2022523653 A JP2022523653 A JP 2022523653A JP 2022523653 A JP2022523653 A JP 2022523653A JP 2022553060 A5 JP2022553060 A5 JP 2022553060A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022523653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022553060A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029739 external-priority patent/WO2021080646A1/en
Publication of JP2022553060A publication Critical patent/JP2022553060A/ja
Publication of JP2022553060A5 publication Critical patent/JP2022553060A5/ja
Priority to JP2026033452A priority Critical patent/JP2026086895A/ja
Pending legal-status Critical Current

Links

JP2022523653A 2019-10-22 2020-04-24 二環式化合物及びピット・ホプキンス症候群の処置におけるそれらの使用方法 Pending JP2022553060A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026033452A JP2026086895A (ja) 2019-10-22 2026-03-03 二環式化合物及びピット・ホプキンス症候群の処置におけるそれらの使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962924452P 2019-10-22 2019-10-22
US62/924,452 2019-10-22
PCT/US2020/029739 WO2021080646A1 (en) 2019-10-22 2020-04-24 Bicyclic compounds and methods for their use in treating pitt hopkins syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026033452A Division JP2026086895A (ja) 2019-10-22 2026-03-03 二環式化合物及びピット・ホプキンス症候群の処置におけるそれらの使用方法

Publications (2)

Publication Number Publication Date
JP2022553060A JP2022553060A (ja) 2022-12-21
JP2022553060A5 true JP2022553060A5 (enExample) 2023-05-01

Family

ID=75620281

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022523653A Pending JP2022553060A (ja) 2019-10-22 2020-04-24 二環式化合物及びピット・ホプキンス症候群の処置におけるそれらの使用方法
JP2026033452A Pending JP2026086895A (ja) 2019-10-22 2026-03-03 二環式化合物及びピット・ホプキンス症候群の処置におけるそれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026033452A Pending JP2026086895A (ja) 2019-10-22 2026-03-03 二環式化合物及びピット・ホプキンス症候群の処置におけるそれらの使用方法

Country Status (13)

Country Link
US (2) US12472177B2 (enExample)
EP (1) EP4048264A4 (enExample)
JP (2) JP2022553060A (enExample)
KR (1) KR102993019B1 (enExample)
CN (1) CN115243688A (enExample)
AU (2) AU2020369431B2 (enExample)
BR (1) BR112022007636A2 (enExample)
CA (1) CA3158406A1 (enExample)
CL (1) CL2022001023A1 (enExample)
CO (1) CO2022006718A2 (enExample)
IL (1) IL292408A (enExample)
WO (1) WO2021080646A1 (enExample)
ZA (1) ZA202204954B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL305132A (en) * 2021-02-12 2023-10-01 Neuren Pharmaceuticals Ltd Preparations for the treatment of the Prader-Willi phenomenon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519127B2 (en) * 2003-09-03 2013-08-27 Mike John Bickerdike Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy
EP1664050B1 (en) 2003-09-03 2015-12-09 Neuren Pharmaceuticals Limited Neuroprotective bicyclic compounds and pharmaceutical compositions containing them
WO2008063311A2 (en) 2006-10-11 2008-05-29 Neuren Pharmaceuticals Limited Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
SI3024463T1 (sl) * 2013-07-25 2020-08-31 Neuren Pharmaceuticals Limited Nevroprotektivne biciklične spojine in postopki za njihovo uporabo pri zdravljenju motenj avtističnega spektra in nevrorazvojnih motenj

Similar Documents

Publication Publication Date Title
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2021169491A5 (enExample)
JP2022068302A5 (enExample)
JP2021028398A5 (enExample)
JP2023116721A5 (enExample)
JP2021038271A5 (enExample)
JP2024023385A5 (enExample)
JP2023022224A5 (enExample)
JP2021184963A5 (enExample)
JP2024016014A5 (enExample)
JP2020042034A5 (enExample)
JP2020127428A5 (enExample)
JP2022523200A5 (enExample)
JP2025506484A5 (enExample)
JP2021518389A5 (enExample)
JP2022060295A5 (enExample)
JP2023100643A5 (enExample)
JP2020171301A5 (enExample)
JP2020120660A5 (enExample)
JP2022537813A5 (enExample)
JP2021524864A5 (enExample)
JP2023085551A5 (enExample)
JP2024534771A5 (enExample)